$AVAH

VIGANO PAUL R sold $8.0M of AVAH (indirect holdings)

VIGANO PAUL R sold 1,000,000 indirectly-held shares of Aveanna Healthcare Holdings, Inc. (AVAH) at $8.00 ($8.00M total) across 3 trades on 2026-06-24.

Original reporting
SEC EDGAR · VIGANO PAUL R
Published Jun 26, 2026, 5:33 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 26, 2026, 5:35 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AVAH
Neutral
medium confidence
Mentioned
$AVAH
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AVAHNeutralLow
01

Why it matters

A large insider sale can modestly pressure sentiment, but without accompanying fundamental news it usually has limited trading impact.

02

Market read

Traders may monitor for follow-on insider activity, but the disclosure alone is unlikely to drive a sustained repricing.

03

What to watch

No 10b5-1 plan is stated, but the filing also doesn’t clarify whether the remaining holdings will be sold soon or whether other insiders are buying.

Relevance 6/10Novelty 5/10Timing: after-hours/filing update on 2026-06-26 for a 2026-06-24 sale

Background

The article is an SEC Form 4 insider transaction disclosure for Aveanna Healthcare Holdings, Inc.

Company-level read

Ticker impact

$AVAHNeutralMedium confidence
Context

Aveanna Healthcare Holdings disclosed a 10% owner indirect open-market sale of 1,000,000 shares at $8.00 on 2026-06-24 via Form 4.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven and typically fades unless follow-on selling continues.

Evidence & confidence

Form 4 insider sales are common and this disclosure lacks a stated 10b5-1 plan, but it also does not include fundamentals, contracts, or regulatory developments.

Market effects

Minimal; this is company-specific insider activity with no sector-wide regulatory or demand signal.

None indicated.

None indicated.

Counterpoint

The sale is indirect and may reflect diversification or pre-planned liquidity needs rather than a bearish view on the business.

Key entities

  • Aveanna Healthcare Holdings, Inc.

    Subject of the Form 4 insider transaction; 10% owner reported an indirect open-market sale.

  • VIGANO PAUL R

    10% owner who sold 1,000,000 shares indirectly at $8.00/share across three trades.

Related articles

$AVAHMed

Bain, KKR, KV Asia shortlisted for Malaysia’s Avisena Healthcare stake sale as valuation hits US$368 million: sources

Bain Capital, KKR and KV Asia have been shortlisted to buy a 20–25% minority stake in Malaysia’s Avisena Healthcare, valuing the company at about RM1.5 billion (US$368m), according to two sources. Binding bids are due by end-July. The stake is estimated at RM300–400m. KKR and Bain declined comment; Avisena and KV Asia did not respond.